Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.600
-0.160 (-4.26%)
At close: Feb 26, 2026
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.4 billion as of February 25, 2026. Its market cap has increased by 19.93% in one year.
Market Cap
1.40B
Enterprise Value
1.31B
Revenue
9.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.60
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.40B, an increase of 264.09%. That is a compound annual growth rate of 33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.40B | 11.24% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.06B |
| Mesoblast | 3.03B |
| Neuren Pharmaceuticals | 1.61B |
| PYC Therapeutics | 1.41B |
| Opthea | 738.77M |
| Immutep | 574.75M |
| Clinuvel Pharmaceuticals | 572.79M |
| Racura Oncology | 432.37M |